Evidence map›Paper›PMID 34642832›Full record

Trial reportThe Psychiatric quarterly2022

Advancing the Science of Recovery: The Utility of the Recovery Assessment Scale in the Prediction of Self-Directed Health and Wellness Outcomes in Adults with a Diagnosis of a Serious Mental Illness.

Karen L Fortuna, Amanda L Myers, Cynthia Bianco, George Mois, Mbita Mbao, Meghan Jenkins Morales, Aaron P Brinen, Stephen J Bartels, Jennifer Hamilton

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in The Psychiatric quarterly, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Karen L FortunaDepartment of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. klfortuna@gmail.com.
Amanda L MyersBrandeis University, Heller School, Waltham, MA, USA.
Cynthia BiancoDepartment of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
George MoisUniversity of Illnois, College of Applied Health Sciences, Champaign, IL, USA.
Mbita MbaoSimmons University School of Social Work, Boston, MA, USA.
Meghan Jenkins MoralesSchool of Social Work, University of Wisconsin-Madison, Madison, WI, USA.
Aaron P BrinenDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Stephen J BartelsThe Mongan Institute, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Jennifer HamiltonCollege of Social Work, The University of Kentucky, Lexington, KY, USA.
Dartmouth College · USBrandeis University · USHarvard University · USSimmons University · USUniversity of Kentucky · USUniversity of Wisconsin–Madison · USVanderbilt University Medical Center · US

Funding

Peer-Delivered and Technology-Assisted Integrated Illness Management and RecoveryK01MH117496 · NIMH · DARTMOUTH-HITCHCOCK CLINIC · PI FORTUNA, KAREN L. · 2019 to 2023
$615k
National Institutes of Mental Health K01MH117496
6 · The paper itself

Abstract

Adults with serious mental illness commonly experience comorbid chronic physical conditions and experience a reduced life expectancy of 10-25 years compared to the general population (Saha et al. in Arch Gen Psychiatry 64(10):1123-31.  2007; Hayes et al. in Acta Psychiatr Scand 131(6):417-25. 2015; Walker et al. in JAMA Psychiatry 72(4):334-41. 2015). Dimensions of personal recovery may have real-world implications that extend beyond functional and mental health outcomes to impact the self-directed health and wellness of adults with serious mental illness. This study examined the predictive utility of the Recovery Assessment Scale with respect to medical self-efficacy, self-management, psychiatric symptoms, and community functioning for adults with serious mental illness. Data were derived from a secondary analysis of baseline and 10-month data collected from a randomized control trial with adults aged 18 years and older with a diagnosis of bipolar disorder, schizoaffective disorder, schizophrenia, or major depressive disorder (N=56). A linear regression was conducted to examine the predictive value of total baseline RAS scores on self-efficacy at 10 months while controlling for study group. This model significantly predicted self-efficacy (F (2, 53) = 13.28, p < .001) and accounted for 36.1% of the variance. Total baseline RAS scores significantly predicted self-efficacy (β = 059, p < .001); specifically, higher baseline RAS scores were associated with greater self-efficacy. A greater degree of recovery may facilitate greater medical self-efficacy in managing chronic disease in people diagnosed with a serious mental illness. Future intervention approaches may consider recovery-focused therapeutic targets such as peer support to promote self-efficacy to manage chronic diseases in people with serious mental illness.

Indexed as

Bipolar DisorderMajor Depressive DisorderMental DisordersPsychotic DisordersSchizophreniaAdultChronic DiseaseHumansFunctioningPatient-reported outcomeRecoverySerious mental illness

Identifiers

PMID34642832
OpenAlexW3206750249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.